Related Experiment Video

Updated: Apr 20, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

354

eEF2K--a new target in breast cancers with combined inactivation of p53 and PTEN

Hege G Russnes1, Carlos Caldas2

  • 1Department of Genetics, Institute for Cancer Research and Department of Pathology, Oslo University Hospital, Oslo, Norway K. G. Jebsen Center for Breast Cancer Research, University of Oslo, Oslo, Norway.

EMBO Molecular Medicine
|December 5, 2014
PubMed

Insights

Human breast cancer is now understood as 10 distinct subtypes based on molecular alterations. Identifying specific drug targets for each subtype is crucial for effective treatment strategies.

Area of Science:

  • Genomics
  • Oncology
  • Molecular Biology

Background:

  • Extensive characterization of somatic molecular alterations in human breast cancer has been performed.
  • This research has led to a re-definition of breast cancer into 10 distinct driver-based subtypes (IntClust subtypes).

Purpose of the Study:

  • To highlight the pressing need for identifying druggable targets tailored to each specific breast cancer subtype.
  • To underscore the importance of subtype-specific therapeutic strategies.

Main Methods:

  • Leveraging comprehensive genomic data from large-scale projects like the Cancer Genome Atlas Network.
  • Analyzing molecular alterations to define distinct intrinsic subtypes (IntClust).

Main Results:

  • Human breast cancer is a heterogeneous disease comprising 10 distinct molecular subtypes.
  • The identification of these subtypes provides a framework for targeted therapy development.

Conclusions:

  • Understanding the molecular landscape of breast cancer subtypes is essential for advancing precision medicine.
  • Future research should focus on discovering and validating subtype-specific therapeutic targets.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.2K
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K